Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Q4 2020 newsletter was released Feb 1, 2021

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jan 23, 2022 3:37pm

531 Views

Post# 34350274

RE:RE:RE:RE:Q4 2020 newsletter was released Feb 1, 2021

winr88 wrote

Hi 99942Apophis
I more than doubled my TLT holdings on Friday because I want to be ready for an early newsletter release. If an early release does not occur a month is not a long time. It is however if I miss news that could drive the SP upward.

Hi winr88 good man, you always seem to get in under the wire. Yes could be a week or a month haha or both.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)